| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/31/2008 | CA2656716A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 01/31/2008 | CA2656239A1 Composition and methods for the enterosorption and management of toxins |
| 01/31/2008 | CA2653640A1 Fungicidal azocyclic amides |
| 01/31/2008 | CA2653056A1 Aldh-2 inhibitors in the treatment of addiction |
| 01/30/2008 | EP1882695A2 Pharmaceutically active compounds and methods of use thereof |
| 01/30/2008 | EP1882692A1 Dimethano-[1,3]dioxocino[6,5-D]pyrimidine-spiro derivatives of tetrodotoxin, process for their synthesis and uses thereof in the treatment of pain |
| 01/30/2008 | EP1882690A2 A process for the preparation of epothilone analogs and intermediates |
| 01/30/2008 | EP1882689A1 Tri- or tetra-substituted-3-aminopyrrolidine derivatives |
| 01/30/2008 | EP1882687A1 Heterocyclic compounds useful as vanilloid receptor antagonists and pharmaceutical compositions containing the same |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1882685A1 Method for producing asymmetric tetrasubstituted carbon atom-containing compound |
| 01/30/2008 | EP1882684A1 Pyrrolidine derivative or salt thereof |
| 01/30/2008 | EP1882480A2 High glycerin containing anti-microbial cleansers |
| 01/30/2008 | EP1882477A1 Drugs, food or drink for improving pancreatic functions |
| 01/30/2008 | EP1882476A1 Preparation of antimicrobial formulation comprising 7-oxo-2-thia-1,5-diazabicyclo[3.3.1]-nonan-2,2-dion |
| 01/30/2008 | EP1882475A1 Method of treating disorders mediated by the fibroblast growth factor receptor |
| 01/30/2008 | EP1882474A1 Prophylactic/therapeutic agent for abnormalities of sugar/lipid metabolism |
| 01/30/2008 | EP1882473A1 Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs |
| 01/30/2008 | EP1882472A1 Drugs, food or drink for improving pancreatic functions |
| 01/30/2008 | EP1881991A1 A1 adenosine receptor agonists |
| 01/30/2008 | EP1881989A1 Thienopyrroles as antiviral agents |
| 01/30/2008 | EP1881988A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1) |
| 01/30/2008 | EP1881987A1 Purine derivatives and their use for treatment of autoimmune diseases |
| 01/30/2008 | EP1881986A2 Tyrosine kinase inhibitors |
| 01/30/2008 | EP1881985A2 Anhydrous crystalline forms of n-ý1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl¨methanesulfonamide |
| 01/30/2008 | EP1881984A1 Inhibitors of nucleoside phosphorylases and nucleosidases |
| 01/30/2008 | EP1881983A1 Pyrrolopyridines useful as inhibitors of protein kinase |
| 01/30/2008 | EP1881982A1 Imidazolone phenylalanine derivatives as vla-4 antagonists |
| 01/30/2008 | EP1881981A1 4, 6-diamino-[1,7] naphthyridine-3-carbonitrile inhibitors of tpl2 kinase and methods of making and using the same |
| 01/30/2008 | EP1881980A2 Novel crystalline forms of tiotropium bromide |
| 01/30/2008 | EP1881979A1 Novel oxadiazole derivatives and their medical use |
| 01/30/2008 | EP1881977A1 Histone deacetylase inhibitors |
| 01/30/2008 | EP1881976A1 Substituted amide derivatives as protein kinase inhibitors |
| 01/30/2008 | EP1881975A1 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 01/30/2008 | EP1881974A2 Phosphonated fluoroquinolones, antibacterial analogs thereof, and methods for the prevention and treatment of bone and joint infections |
| 01/30/2008 | EP1881968A2 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds |
| 01/30/2008 | EP1881967A1 Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics |
| 01/30/2008 | EP1881965A1 2-amino-4-phenylquinazoline derivates and their use as hsp90 modulators |
| 01/30/2008 | EP1881962A2 Thiosuccinic acid derivatives and the use thereof |
| 01/30/2008 | EP1881961A1 New haloalkylsulfone substituted compounds useful for treating obesity and diabetes |
| 01/30/2008 | EP1881960A1 Novel specific caspase-10 inhibitors |
| 01/30/2008 | EP1881958A1 Diacylglycerol acyltransferase inhibitors |
| 01/30/2008 | EP1881950A1 New compounds i |
| 01/30/2008 | EP1881848A2 Prevention of hiv-infection with tmc278 |
| 01/30/2008 | EP1881847A2 Injection solution for rna |
| 01/30/2008 | EP1881839A2 Compositions of bakuchiol and methods of making the same |
| 01/30/2008 | EP1881837A2 Method of treating lymphangioleiomyomatosis (lam) |
| 01/30/2008 | EP1881836A1 Method for preparing and using water-based steroid pheromone compositions |
| 01/30/2008 | EP1881835A1 Triazine compounds and compositions thereof for the treatment of cancers |
| 01/30/2008 | EP1881834A1 Pteridines useful as hcv inhibitors and methods for the preparation thereof |
| 01/30/2008 | EP1881833A1 Compositions for the treatment of psoriasis |
| 01/30/2008 | EP1881832A2 Use of flibanserin in the treatment of chronic pain |
| 01/30/2008 | EP1881831A1 Sustained release solid pharmaceutical composition of 1-(2,3,4-trimethoxybenzyl)piperazine and a method for the preparation thereof |
| 01/30/2008 | EP1881830A1 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives the treatment of infertility |
| 01/30/2008 | EP1881829A2 Unsolvated and host-guest solvated crystalline forms of (2e,4s)-4-[(n-{[(2r)-1-isopropylpiperidin-2-yl]-carbonyl}-3-methyl-l-valyl)(methyl)amino]-2,5-dimethylhex-2-enoic acid and their pharmaceutical uses |
| 01/30/2008 | EP1881828A1 Treatment of hcv with subtherapeutic doses of ribavirin |
| 01/30/2008 | EP1881827A1 Fused thiazole derivatives as kinase inhibitors |
| 01/30/2008 | EP1881826A1 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2) |
| 01/30/2008 | EP1881825A2 Hiv integrase inhibitors |
| 01/30/2008 | EP1881824A1 Use of docosahexaenoic glycerides for the treatment of tumorous diseases |
| 01/30/2008 | EP1881823A1 Compositions and methods for treatment of eye disorders |
| 01/30/2008 | EP1881819A1 Extrusion process for making compositions with poorly compressible therapeutic compounds |
| 01/30/2008 | EP1881760A2 Antimicrobial therapy for bacterial infections |
| 01/30/2008 | EP1881757A2 Dronabinol treatment of delayed chemotherapy-induced nausea and vomiting |
| 01/30/2008 | EP1881756A2 Treating microvasculature diseases with acetyl cholinesterase inhibitors |
| 01/30/2008 | EP1689350B1 Use of osteopontin in dental formulations |
| 01/30/2008 | EP1599477B1 Sulfonamide substituted xanthine derivatives for use as pepck inhibitors |
| 01/30/2008 | EP1521757B1 tricyclic spiropiperidines or spiropyrrolidines |
| 01/30/2008 | EP1468110A4 Molecular signatures of commonly fatal carcinomas |
| 01/30/2008 | EP1280420B1 Natural vegetable oil concentrated in unsaponifiable matters as food ingredient |
| 01/30/2008 | EP1163254B1 Trpm-2 antisense therapy |
| 01/30/2008 | CN101115846A Mammalian genes involved in infection |
| 01/30/2008 | CN101115835A CpG-ODN of flanking sequence having stem-loop and non-CpG basic sequence for treating dermatosis |
| 01/30/2008 | CN101115834A Apoptosis-specific eif-5a and polynucleotides encoding same |
| 01/30/2008 | CN101115765A Modified 5'-phosphonates of azt potential antiviral drugs |
| 01/30/2008 | CN101115764A New macrolides |
| 01/30/2008 | CN101115763A Novel polyphenol glycoside derived from acerola |
| 01/30/2008 | CN101115761A Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 01/30/2008 | CN101115760A Pyrrolopyrazoles, potent kinase inhibitors |
| 01/30/2008 | CN101115759A Cci-779 polymorph and use thereof |
| 01/30/2008 | CN101115757A Method for purifying noroxymorphone compounds |
| 01/30/2008 | CN101115756A Tetracyclic imidazo-benzodiazepines as GABA receptors modulators |
| 01/30/2008 | CN101115755A Pyrazolo-pyrimidine derivatives as MGLUR2 antagonists |
| 01/30/2008 | CN101115753A Bridged ring nk1 antagonists |
| 01/30/2008 | CN101115752A 4- (4- (imidazol-4-yl) pyrimidin-2-ylamino) benzamides as cdk inhibitors |
| 01/30/2008 | CN101115751A Tricyclic delta-opioid modulators |
| 01/30/2008 | CN101115749A Aminopyrimidine compounds and methods of use |
| 01/30/2008 | CN101115747A Atm inhibitors |
| 01/30/2008 | CN101115745A Mitotic kinesin inhibitors |
| 01/30/2008 | CN101115744A Process for the preparation of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline,their intermediates and crystalline salts thereof |
| 01/30/2008 | CN101115742A Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 01/30/2008 | CN101115741A 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters |
| 01/30/2008 | CN101115740A Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 01/30/2008 | CN101115738A Pyrazolylamino substituted quinazoles for the treatment of cancer |
| 01/30/2008 | CN101115737A Novel salt form of a dopamine agonist |
| 01/30/2008 | CN101115736A Potassium channel modulating agents and their medical use |
| 01/30/2008 | CN101115735A Glucagon receptor antagonists, preparation and therapeutic uses |
| 01/30/2008 | CN101115731A Oxadiazole derivatives as DGAT inhibitors |
| 01/30/2008 | CN101115728A Triazole substituted aminobenzophenone compounds |
| 01/30/2008 | CN101115727A Compounds useful for inhibiting chk1 |